Sponsored Links


Displaying bosentan PowerPoint Presentations

Pulmonary Arterial Hypertension Associated with a ... PPT

Presentation Summary : Title: Pulmonary Arterial Hypertension Associated with a Neuroendocrine Pancreatic Tumor Successfully Treated with Bosentan and Fluoxetine Author

Source : http://lungtherapeutics.com/appDocs/Pulmonary_Arterial_Hypertension.ppt

BENEFIT: Study design - CardioSource - Home PPT

Presentation Summary : Bosentan for inoperable chronic thromboembolic pulmonary hypertension (CTEPH) and post-pulmonary endarterectomy pulmonary hypertension A pre-defined subgroup analysis ...

Source : http://www.cardiosource.com/img/Lang_benefit.ppt

Pulmonary Hypertension - Welcome! — Pediatrics - UNC School ... PPT

Presentation Summary : Bosentan induces metabolism ... with little systemic hypotension Recommended for WHO Class II and III Sildenafil In animal models of acute pulmonary hypertension ...

Source : http://pediatrics.med.unc.edu/education/current-residents/rotation-information/pediatric-intensive-care-unit/PHTN_Resident_Lecture.ppt

SSPAH Template PPT

Presentation Summary : Bosentan is provided twice daily at a maintenance dose of 125 mg bid. Ambrisentan is a once-daily medication with two dosage levels, 5 mg or 10 mg. Bosentan is a ...

Source : http://www.medipixproductions.net/files/simplyspeaking2010/decks/pah/05_waxman.ppt

Pulmonary Hypertension for the Internist - Welcome to the UNC ... PPT

Presentation Summary : Pulmonary Hypertension 2009 Jimmy Ford, MD Pulmonary Hypertension Program Division of Pulmonary and Critical Care Medicine ... for both placebo and bosentan.

Source : http://medicine.med.unc.edu/education/internal-medicine-residency-program/files/ppt/11.9.09%20Ford%20Pulmonary%20Hypertension%20for%20the%20Internist.ppt/at_download/file

PowerPoint Presentation PPT

Presentation Summary : Although relatively little evidence supports combined use of bosentan and epoprostenol, bosentan treatment was continued during the initiation of epoprostenol therapy.

Source : http://phdres.caregate.net/curriculum/ppt_files/PAH%20talk%202006/zxs.ppt

Idiopathic Pulmonary Fibrosis Standards of Care ... PPT

Presentation Summary : Idiopathic Pulmonary Fibrosis Standards of Care & Investigational Therapies Stephen K. Frankel, MD, FCCP Assistant Professor, Interstitial Lung Disease Program

Source : http://www.coalitionforpf.org/wp-content/uploads/2013/02/FrankelLivingwithIPF.ppt

A Framework for Diagnosing and Treating CTEPH PPT

Presentation Summary : Bosentan in CTEPH (BENEFIT) Riociguat for the Treatment of CTEPH (CHEST-1) Methods . Riociguat for CTEPH Secondary Endpoints . Riociguat for CTEPHSecondary Endpoints ...

Source : http://img.medscape.com/images/815/301/815301_slides.pptx

Cardiac Glycosides and Therapy of Congestive Heart Failure PPT

Presentation Summary : Cardiac Glycosides and Therapy of Congestive Heart Failure ... Natriuretic peptide Bosentan (Tracleer®) Endothelin receptor antagonist Epoprostenol ...

Source : http://iris.nyit.edu/still/Cardiology/2003_04/17_Cardiac_Glycosides_Therapy_Congestive_Heart_Failure.ppt

Presentación de PowerPoint - EL COMPRIMIDO PPT

Presentation Summary : Bosentan can be efficacious in treating severe active digital ulcers in patients with systemic scleroderma. Bosentan appears to act rapidly, ...

Source : http://www.elcomprimido.com/INFORMED/PDC_HUSD18_AUTOINMUNES/PDC_HUSD18_Dr_Pallares_EndotelinaBiologicosEAS_parte1.ppt

Slide 1 PPT

Presentation Summary : Bosentan: ~35-40k per year Sildenafil: ~12-15k per year Inhaled Iloprost: ~60k per year IV Prostacyclins: ~60-120k per year Pulmonary Arterial Hypertension ...

Source : http://sciotocountymedicalsociety.org/documents/Franco-PortmanGrandRoundsSept2008.ppt

Pulmonary Arterial Hypertension PPT

Presentation Summary : Pulmonary Embolism Part of VTE Potentially fatal Can complicate hospital admission Preventable Tests poor Risk factors Surgery ... Bosentan, sitaxentan PDE4 ...

Source : http://www.mededcoventry.com/Specialties/Respiratory/Week%203%20-%20PE%20PAH%20and%20sleep.ppt

Pulmonary Complications of Sickle Cell Disease PPT

Presentation Summary : Pulmonary Complications of Sickle Cell ... ASSET-1 and 2: Bosentan in PH of SCD Randomized placebo controlled trials of bosentan in PAH or PVH of SCD Industry ...

Source : http://www.bumc.bu.edu/im-residency/files/2014/04/Pulmonary-Complications-of-Sickle-Cell-Disease-Klings-2.3.14.ppt

Pulmonary Hypertension: The Other High Blood Pressure PPT

Presentation Summary : Pulmonary Hypertension: The Other High Blood Pressure ... Twice-daily bosentan (Tracleer) was the first of 4 currently approved oral therapies; ...

Source : http://lchpediatrics.weebly.com/uploads/1/1/5/4/11548021/pulmonary_hypertension.ppt

Pulmonary Hypertension - Welcome to the Association of ... PPT

Presentation Summary : Bosentan. Sildenafil. Pharmacologic Treatment. Group 3 Pulmonary Hypertension. Ambrisentan. Bosentan. Epoprostenol IV. Iloprost Inhaled. Sildenafil. Group 4 Pulmonary ...

Source : http://apacvs.org/multimedia/files/conferences/2013/Critical-Care/OGowan_Pulmonary%20Hypertension.pptx

Pre-clinical data: An update - Krause und Pachernegg - Verlag ... PPT

Presentation Summary : Addition of bosentan to macitentan did not lead to further reductions in MAP Macitentan then vehicle Macitentan then bosentan -50 -40 -30 -20 -10 0 Animal model p ...

Source : http://www.kup.at/kup/bildsatz/308.ppt

Slide 1 PPT

Presentation Summary : Division of Pulmonary, Critical Care, ... Bosentan: a novel agent for the treatment of pulmonary hypertension. Int J Clin Pract. 2004;58:69-73. Walter N, ...

Source : http://www.coalitionforpf.org/wp-content/uploads/2013/03/ClinicalTrialsSahn.ppt

Slide 1 PPT

Presentation Summary : ... metabolism Entothelin Receptor Antagonists Increased conc of ET-1 found in the plasma and lung tissue of pts with PAH Bosentan competitive inhibitor of ET A ...

Source : http://www.advocatehealth.com/documents/residents/cmc/cardiology/ccpportohtn.ppt

Sponsored Links

Report a violation: If you find a presentation that is using one of your presentation without permission, contact us immidiately at

© XPowerPoint.com